Process for preparing Imatinib
View Patent ↗A novel process is disclosed for producing Imatinib, using the precursor 2-chloro-4-(3-pyridyl)-pyrimidine, thus improving Imatinib preparation via an alternative synthetic route, avoiding the use of the toxic reagent cyanamide.
1. A process for preparing Imatinib or an addition salt thereof, wherein the compound 2-chloro-4-(3-pyridyl)-pyrimidine, is used as starting material, wherein the compound 2-chloro-4-(3-pyridyl)-pyrimidine is reacted with 2-amino-4-nitrotoluene to obtain N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidine-amine, which is subsequently hydrogenated to obtain N-(5-amino-2-methyl)-4-(3-pyridyl)-pyrimidine-amine, which is reacted with 4-(4-methyl-piperazine-1-ylmethyl)-benzoyl chloride, as depicted in Scheme 4.
2. A process for preparing Imatinib or an addition salt thereof, according to claim 1 , the process comprising:
providing a mixture of N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine and 4-(4-methyl-piperazinomethyl)-benzoyl chloride in an organic solvent;
heating the mixture to elevated temperature for a time period sufficient to allow completing the reaction;
cooling the reaction mixture and adjusting the pH;
evaporating the solvent, washing and extracting the residue; and
optionally purifying the reaction product.
3. The process for preparing Imatinib base or an addition salt thereof, according to claim 2 , wherein the crude Imatinib base is purified by using a method selected from the group consisting of precipitation, crystallization, slurrying, washing in a suitable solvent, column chromatography, and any combination of methods thereof.
4. The process for preparing Imatinib or an addition salt thereof, according to claim 3 , wherein the crude Imatinib base is purified by slurrying procedure in a solvent selected from the group consisting of ethyl acetate, diethyl ether, diisopropyl ether, methyl tert-butyl ether, hexane, cyclohexane, petroleum ether and mixtures thereof.
5. The process for preparing Imatinib base or an addition salt thereof, according to claim 4 , wherein crude Imatinib base is purified by slurrying procedure in ethyl acetate.